Link copied to clipboard!

Time Medical International Ventures announces partnership for installation of Inter-Op MRI Suite 

IMT News Desk
IMT News Desk
· 2 min read

The intraoperative MRI platform is designed to transform intraoperative imaging by providing surgeons with real-time visualization during complex neurosurgical procedures, enabling unprecedented precision, safety, and surgical control in procedures that traditionally rely on limited visual feedback.

Time Medical International Ventures (India) Private Limited (“Time Medical India”), a wholly owned subsidiary of Fischer Medical Ventures Limited and a global leader in advanced medical imaging solutions, has entered into a partnership with Parul Sevashram Hospital, Vadodara, to install its revolutionary DRIS–iMRI Medharanya Suite, an AI-enabled next-generation portable intraoperative MRI system. 

Time Medical has developed a revolutionary new variant of MRI imaging technology — DRIS–iMRI Medharanya, an AI-enabled, next-generation, portable and specialized MRI system integrating Augmented Reality (AR), Artificial Intelligence (AI), Machine Learning (ML), and Exoscope technologies. The intraoperative MRI platform is designed to transform intraoperative imaging by providing surgeons with real-time visualization during complex neurosurgical procedures, enabling unprecedented precision, safety, and surgical control in procedures that traditionally rely on limited visual feedback.  

Time Medical International Ventures has entered into a partnership to install its first Modern Brain Suite: the DRIS–iMRI Medharanya system at Parul Sevashram Hospital, Vadodara. Parul Sevashram Hospital’s vision of “Health for All” and its commitment to accessible, high-quality healthcare closely aligns with TMIV’s focus on expanding access to advanced imaging technologies and improving clinical outcomes through innovation-driven diagnostics and interventional solutions. 

Parul Sevashram Hospital serves as the teaching hospital of Parul Institute of Medical Sciences & Research, a constituent institute of Parul University, Vadodara – one of India’s largest multidisciplinary private universities and the youngest in the country to receive a NAAC A++ accreditation in its first assessment cycle. Spread across a 125-acre eco-friendly campus, Parul University comprises 34 constituent institutes offering 250+ programmes across 21 faculties, including Medicine, Engineering, Pharmacy, Ayurveda, Homoeopathy, Management, Law, and Design, to a student community of over 43,000, including more than 2,500 international students from over 68 countries. Through this upcoming partnership, the DRIS–iMRI Medharanya Suite is expected to strengthen the university’s academic and clinical ecosystem, giving medical students, residents, and faculty at Parul University hands-on exposure to next-generation neurosurgical imaging technology. 

Read Next

Tata AIA’s ‘Sampoorna Care – Cancer’ To Ease Cancer Treatment
News
August 7, 2026

Tata AIA’s ‘Sampoorna Care – Cancer’ To Ease Cancer Treatment

This insurance bridges the gap by combining cancer protection with regular income support. A cancer diagnosis affects more than a person’s health. It interrupts work, reduces household income and places additional financial pressure on families. Traditional health insurance covers hospital bills, but many families face ongoing expenses such as home loan instalments, rent, school fees […]
Article by: IMT News Desk
Metropolis Healthcare 1QFY27 Reports Strong volume growth
News
August 7, 2026

Metropolis Healthcare 1QFY27 Reports Strong volume growth

METROHL’s 1QFY27 performance was broadly in line with EE across all fronts. According to a release issued, METROHL’s 1QFY27 performance was broadly in line with EE across all fronts. Strong volume growth, higher contribution from margin-accretive TruHealth and traction in the speciality segments continued to support double digit growth. Specialty mix aids margin outperformance: Revenue grew […]
Article by: IMT News Desk
HCG Q1 Revenue Up 13% YoY 
News
August 7, 2026

HCG Q1 Revenue Up 13% YoY 

HCG delivered revenue of INR 6,951 Mn in Q1 FY27, reflecting ~13% YoY growth Healthcare Global Enterprises Limited (HCG), India’s largest dedicated cancer private hospital network, under the brand “HCG”, has announced its financial results for the quarter ended 30th June 2026.  Dr. B. S. Ajaikumar, Founder and Non-Executive Chairman, HealthCare Global Enterprises Ltd., said, “The strong start to FY27 reflects the resilience of […]
Article by: IMT News Desk
Pfizer Transforms Early Cancer Detection Across Assam
News
August 6, 2026

Pfizer Transforms Early Cancer Detection Across Assam

Partnership with Tata Cancer Care Foundation reaches over 1 million beneficiaries  Pfizer today celebrated its partnership with the Tata Cancer Care Foundation (TCCF), that has reached more than one million beneficiaries across Assam, Jharkhand, Andhra Pradesh, Maharashtra and Odisha by strengthening cancer awareness, early detection and frontline healthcare capacity. The partnership has supported over 993,000 screenings for oral, breast and cervical cancers, trained nearly 25,000 healthcare providers and strengthened community-based referral pathways to support […]
Article by: IMT News Desk